Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-132854
Filing Date
2024-12-31
Accepted
2024-12-31 16:15:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2432276-1_424b3.htm 424B3 170788
2 GRAPHIC lg_aclaristherapeutic-4c.jpg GRAPHIC 22456
  Complete submission text file 0001104659-24-132854.txt   202893
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283942 | Film No.: 241593196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)